1. Silver/chiral pyrrolidinopyridine relay catalytic cycloisomerization/(2 + 3) cycloadditions of enynamides to asymmetrically synthesize bispirocyclopentenes as PDE1B inhibitors.
- Author
-
Jiang, Jing, Zhou, Jin, Li, Yang, Peng, Cheng, He, Gu, Huang, Wei, Zhan, Gu, and Han, Bo
- Subjects
RING formation (Chemistry) ,TRANSITION metal catalysts ,LEWIS bases ,SILVER ,TRANSITION metals ,ASYMMETRIC synthesis - Abstract
Significant progress has been made in asymmetric synthesis through the use of transition metal catalysts combined with Lewis bases. However, the use of a dual catalytic system involving 4-aminopyridine and transition metal has received little attention. Here we show a metal/Lewis base relay catalytic system featuring silver acetate and a modified chiral pyrrolidinopyridine (PPY). It was successfully applied in the cycloisomerization/(2 + 3) cycloaddition reaction of enynamides. Bispirocyclopentene pyrazolone products could be efficiently synthesized in a stereoselective and economical manner (up to >19:1 dr, 99.5:0.5 er). Transformations of the product could access stereodivergent diastereoisomers and densely functionalized polycyclic derivatives. Mechanistic studies illustrated the relay catalytic model and the origin of the uncommon chemoselectivity. In subsequent bioassays, the products containing a privileged drug-like scaffold exhibited isoform-selective phosphodiesterase 1 (PDE1) inhibitory activity in vitro. The optimal lead compound displayed a good therapeutic effect for ameliorating pulmonary fibrosis via inhibiting PDE1 in vivo. Cycloisomerization/cyclization cascade reactions for yne-enones and enyamides can be used to construct diverse fused furans, however, the corresponding (2 + n) reaction remains challenging. Here, the authors report cycloisomerization/(2 + 3) cycloadditions catalyzed by silver acetate and a modified chiral pyrrolidinopyridine relay system, to generate bispirocyclopentene pyrazolone products with isoform-selective phosphodiesterase 1 (PDE1) inhibitory activity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF